Synovate Healthcare launches first Oncology Monitor in India
5 September 2007
LONDON — Synovate Healthcare, the healthcare arm of international market research agency, Synovate, today announced the launch of its India Oncology Monitor – the first of its kind in the country.
The Synovate Healthcare India Oncology Monitor will track drug-prescribing behaviour in major oncology treatment centres across India, covering an estimated 80% of the country's oncology drug market. Following its launch in China, Korea and Australia last year, the Synovate monitor now covers all major established pharmaceutical markets in Asia Pacific. Coupled with a long-time presence in the US, Europe and Japan, the Synovate Healthcare Global Oncology Monitor provides the most geographically comprehensive treatment data on the market. Future expansion of the monitor will focus on Asia Pacific?s emerging pharmaceutical markets.
Commented Kelly Price, Associate Director of the Asia Pacific Oncology Monitors, "The launch of the monitor in India will fill what has been an information vacuum. Now, clients can benefit from a methodology that collects Indian oncology data in a globally consistent manner whilst recognising the uniqueness of this market."
Added Monica Gangwani, Head of Synovate Healthcare India, "Given the dynamic scenario in the Indian Healthcare market, the need for specialised healthcare research to help equip marketers in minimising risks and formulating better strategies cannot be overemphasised. The launch of the oncology monitor in India is a big step in the right direction. This will help players in the oncology market to leverage the synergies between ad hoc research and oncology monitor data."
Jackie Ilacqua, Synovate Healthcare's Global Head of Oncology, said, "Our continued expansion provides our clients with one truly global source for all their oncology needs. We expect to continue the expansion into other countries of interest to our clients and have exciting plans for expanding our oncology portfolio overall."
For more information, please contact Kelly Price or on + 8621-6132-2291.
Contact(s) for this press release
|
Jo Butcher
Senior Marketing Manager Synovate Healthcare |
|
|
Tel: +44 20 3059 5000 / (DL) +44 20 3059 4670 |
|
|
Madhurima Bhatia
Head of Marketing and Communications Synovate India |
|
|
Tel: +91 11 4618 3010 |
|
About the Synovate Healthcare Global Oncology Monitor
The Synovate Healthcare Global Oncology Monitor covers 11 countries globally (UK, France, Italy, Germany, Spain, US, Japan, Australia, China, Korea and India) and is subscribed to by 50 companies worldwide. It is the largest and most frequently updated international drug-treated oncology patient sample.
About Synovate Healthcare
Synovate Healthcare is the global specialist healthcare market research arm of Synovate, dedicated to delivering marketing insights to the pharmaceutical and healthcare industries. Synovate Healthcare employs over 500 healthcare market research professionals across Europe, US, Canada, Asia Pacific and Japan and offers syndicated and custom research as well as global fieldwork capabilities.
More information on Synovate Healthcare can be found at www.synovate.com/healthcare.
About Synovate
Synovate generates insights to help clients drive competitive brand, product and customer experience strategies. Now part of Ipsos, with offices in over 80 countries, our approach combines best in class global research capabilities with personalised service, local knowledge and the flexibility to create teams and processes that meet clients' specific requirements. At Synovate, our clients sit at the top of our organisational chart, driving us to continually develop more innovative research solutions that predict actual business outcomes.
For more information on Synovate visit www.synovate.com.